Independent guide
TRICARE coverage for Wegovy, Ozempic, and Mounjaro
Weight-loss GLP-1 drugs and diabetes GLP-1 drugs follow different TRICARE rules.
Last reviewed October 2, 2026 · Confirm time-sensitive details with the official program.
Weight loss and diabetes are different benefits
TRICARE’s pharmacy FAQ says Wegovy, Saxenda, and Zepbound can be covered for weight management on TRICARE Prime, TRICARE Prime Remote, the US Family Health Plan, TRICARE Select, TRICARE Young Adult, TRICARE Reserve Select, TRICARE Retired Reserve, and the Continued Health Care Benefit Program. You must meet the clinical criteria, use a network provider, and get prior authorization.
The same FAQ says TRICARE does not cover those weight-loss drugs for TRICARE For Life. A person in that situation pays the full cost even with an approved prior authorization. Beginning July 1, 2026, Medicare Part D has a separate GLP-1 bridge for some weight-loss drugs.
Ozempic, Trulicity, Mounjaro, and Victoza are covered to treat type 2 diabetes when the clinical criteria and prior-authorization rules are met. That diabetes coverage is not the same benefit as weight-loss coverage.
Check the drug in the TRICARE Formulary Search Tool and read the official pages before you fill a prescription.